Page 1 of Clinical Trials for Antiviral Agents, 6520 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Last Updated: December 4, 2009
Condition(s): Chronic Hepatitis B
2
Recruiting
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Last Updated: April 30, 2012
Condition(s): Hepatitis C
3
Completed
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
Last Updated: May 17, 2012
Condition(s): Hepatitis C, Chronic
4
Completed
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
Last Updated: September 3, 2010
Condition(s): Hepatitis C Virus; Chronic Liver Disease; Viral Hepatitis; Therapeutic Uses; Antiviral Agents
5
Completed
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Last Updated: June 6, 2011
Condition(s): Hepatitis C, Chronic; Liver Diseases; Virus Diseases
6
Recruiting
Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection
Last Updated: December 17, 2008
Condition(s): Hepatitis B, Chronic
7
Recruiting
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Last Updated: February 6, 2009
Condition(s): Hepatocellular Carcinoma; Hepatitis B Virus; Recurrence
8
Active, not recruiting
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390
Last Updated: April 26, 2012
Condition(s): Hepatitis C; Thrombocytopaenia
9
Terminated
TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin
Last Updated: April 6, 2012
Condition(s): Hepatitis C Virus
10
Active, not recruiting
Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers
Last Updated: April 27, 2007
Condition(s): Hepatitis C
11
Recruiting
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Last Updated: April 2, 2012
Condition(s): Hepatitis B; Liver Transplantation
12
Completed
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin
Last Updated: January 10, 2012
Condition(s): Chronic Hepatitis C Infection
13
Enrolling by invitation
Antiviral Treatment of Chronic Lymphocytic Leukemia
Last Updated: July 29, 2011
Condition(s): Chronic Lymphocytic Leukemia
14
Enrolling by invitation
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
Last Updated: April 28, 2011
Condition(s): Chronic Hepatitis C Virus Infection
15
Terminated
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
Last Updated: December 1, 2011
Condition(s): Hepatitis C
16
Completed
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.
Last Updated: January 13, 2009
Condition(s): Hepatitis, Chronic; Hepatitis C Virus
17
Terminated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ACH-0137171 in Subjects With Chronic Hepatitis C Infection
Last Updated: May 10, 2007
Condition(s): HCV Infection
18
Not yet recruiting
Nutritional Support During Antiviral Therapy for Hepatitis C
Last Updated: February 10, 2009
Condition(s): Hepatitis C; Weight Loss
19
Active, not recruiting
Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Nonresponders to Antiviral Therapy
Last Updated: February 20, 2012
Condition(s): Chronic Hepatitis C
20
Completed
TMC310911-TiDP21-C201 - A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-naive HIV-1-infected Patients
Last Updated: March 6, 2012
Condition(s): HIV-1 Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Antiviral+Agents

Page 1 of Clinical Trials for Antiviral Agents, 6520 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About